Literature DB >> 19597645

Protection with bacteriophage KØ1 against fatal Klebsiella pneumoniae-induced burn wound infection in mice.

Rohit Malik1, Sanjay Chhibber.   

Abstract

BACKGROUND AND
PURPOSE: Bacteriophages, viruses that cause lysis of bacteria, can serve as an effective tool for the control of infections, especially those caused by multiple drug-resistant organisms. Klebsiella pneumoniae is one of the most predominant pathogens associated with burn wound infections, causing considerable morbidity and mortality. This study investigated the protective effect of K. pneumoniae-specific bacteriophage KØ1 isolated from the environment in a mouse model of burn wound infection induced by K. pneumoniae.
METHODS: The toxicity of the bacteriophage and its in vivo survival and stability in mice was assessed. The fatal dose of K. pneumoniae was ascertained in third-degree burn wound infection. The protective effect of the bacteriophage administered via the subcutaneous or intraperitoneal route was investigated.
RESULTS: A substantial decrease in the bacterial load of blood, peritoneal lavage, and lung tissue was noted following treatment with the bacteriophage preparation. The decrease in microbial count was evident when the bacteriophage was administered either via the subcutaneous or intraperitoneal route.
CONCLUSION: These results suggest that bacteriophages have the potential to modulate the course of burn wound infection caused by K. pneumoniae.

Entities:  

Mesh:

Year:  2009        PMID: 19597645

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  8 in total

1.  Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples.

Authors:  S Kumari; K Harjai; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

Review 2.  Bacteriophage therapy against Enterobacteriaceae.

Authors:  Youqiang Xu; Yong Liu; Yang Liu; Jiangsen Pei; Su Yao; Chi Cheng
Journal:  Virol Sin       Date:  2015-02-03       Impact factor: 4.327

Review 3.  Topical antimicrobials for burn wound infections.

Authors:  T Dai; Y Y Huang; S K Sharma; J T Hashmi; D B Kurup; M R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2010-06

Review 4.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

5.  Bacteriophage ZCKP1: A Potential Treatment for Klebsiella pneumoniae Isolated From Diabetic Foot Patients.

Authors:  Omar A Taha; Phillippa L Connerton; Ian F Connerton; Ayman El-Shibiny
Journal:  Front Microbiol       Date:  2018-09-11       Impact factor: 5.640

6.  Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model.

Authors:  ArunKumar GaneshPrasad; Saisubramanian Nagarajan; Niranjana Sri Sundaramoorthy; Subramaniam Thothathri; Muthumeenakshi Bhaskaran
Journal:  AMB Express       Date:  2021-02-15       Impact factor: 3.298

7.  Klebsiella pneumoniae subsp. pneumoniae-bacteriophage combination from the caecal effluent of a healthy woman.

Authors:  Lesley Hoyles; James Murphy; Horst Neve; Knut J Heller; Jane F Turton; Jennifer Mahony; Jeremy D Sanderson; Barry Hudspith; Glenn R Gibson; Anne L McCartney; Douwe van Sinderen
Journal:  PeerJ       Date:  2015-07-28       Impact factor: 2.984

Review 8.  Considerations for the Use of Phage Therapy in Clinical Practice.

Authors:  Gina A Suh; Thomas P Lodise; Pranita D Tamma; Jane M Knisely; Jose Alexander; Saima Aslam; Karen D Barton; Erica Bizzell; Katherine M C Totten; Joseph L Campbell; Benjamin K Chan; Scott A Cunningham; Katherine E Goodman; Kerryl E Greenwood-Quaintance; Anthony D Harris; Shayla Hesse; Anthony Maresso; Veronique Nussenblatt; David Pride; Michael J Rybak; Zoe Sund; David van Duin; Daria Van Tyne; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2022-01-18       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.